Brady Martz Wealth Solutions’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.36M Sell
9,027
-1
-0% -$256 0.35% 61
2026
Q2
$2.27M Buy
9,028
+228
+3% +$49.1K 0.34% 66
2026
Q1
$1.91M Buy
8,800
+1,525
+21% +$338K 0.33% 68
2025
Q4
$1.66M Buy
7,275
+1,272
+21% +$290K 0.29% 67
2025
Q3
$1.39M Buy
6,003
+13
+0.2% +$2.65K 0.25% 73
2025
Q2
$1.11M Sell
5,990
-33
-0.5% -$6.13K 0.22% 86
2025
Q1
$1.26M Buy
6,023
+22
+0.4% +$4.28K 0.29% 72
2024
Q4
$1.05M Buy
+6,001
New +$1.1M 0.25% 80

Other funds holding ABBV

Brady Martz Wealth Solutions's ABBV Position: Q3 2026 in Review

Brady Martz Wealth Solutions reduced its AbbVie (ABBV) stake by 0.01% in Q3 2026, selling an estimated $256 and leaving 9,027 shares worth $2.36M. The position accounts for 0.35% of the portfolio, ranked #61.

Brady Martz Wealth Solutions first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 3,879 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Brady Martz Wealth Solutions held 9,027 shares of AbbVie worth $2.36M as of Q3 2026.
  • Brady Martz Wealth Solutions sold 1 AbbVie share in Q3 2026, an estimated $256.
  • AbbVie made up 0.35% of Brady Martz Wealth Solutions's portfolio in Q3 2026, its #61 holding.
  • Brady Martz Wealth Solutions first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 3,879 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Brady Martz Wealth Solutions's 13F filing for Q3 2026, filed 5 Nov 2026.